Pictet Asset Management
TECH icon

Pictet Asset Management’s Bio-Techne TECH Stock Holding History

Pictet Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Sell
31,070
-79
-0.3% -$4.27K ﹤0.01% 901
2026
Q1 		$1.63M Buy
31,149
+1,678
+6% +$101K ﹤0.01% 951
2025
Q4 		$1.73M Sell
29,471
-967
-3% -$58.8K ﹤0.01% 933
2025
Q3 		$1.69M Sell
30,438
-1,212
-4% -$64.9K ﹤0.01% 910
2025
Q2 		$1.63M Sell
31,650
-67,270
-68% -$3.38M ﹤0.01% 909
2025
Q1 		$5.8M Buy
98,920
+5,260
+6% +$356K 0.01% 769
2024
Q4 		$6.75M Sell
93,660
-871
-0.9% -$64K 0.01% 754
2024
Q3 		$7.56M Buy
94,531
+14,051
+17% +$1.06M 0.01% 723
2024
Q2 		$5.77M Sell
80,480
-614
-0.8% -$45.2K 0.01% 758
2024
Q1 		$5.71M Sell
81,094
-1,285
-2% -$91.9K 0.01% 756
2023
Q4 		$6.36M Sell
82,379
-229,279
-74% -$15.1M 0.01% 746
2023
Q3 		$21.2M Buy
+311,658
New +$24.6M 0.03% 440

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pictet Asset Management's TECH Position: Q2 2026 in Review

Pictet Asset Management reduced its Bio-Techne (TECH) stake by 0.25% in Q2 2026, selling an estimated $4.27K and leaving 31,070 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #901.

Pictet Asset Management first reported a position in TECH in Q3 2023 and has held it in 12 quarters since. The position peaked at $21.2M in Q3 2023. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Pictet Asset Management held 31,070 shares of Bio-Techne worth $2.2M as of Q2 2026.
  • Pictet Asset Management sold 79 Bio-Techne shares in Q2 2026, an estimated $4.27K.
  • Bio-Techne made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #901 holding.
  • Pictet Asset Management first reported a position in Bio-Techne in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Bio-Techne position peaked at $21.2M in Q3 2023.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.